Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01396551 · ClinicalTrials.gov registry record · NA
Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy
A NA study, sponsored by Varian, a Siemens Healthineers Company.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT01396551 is a NA study that has completed, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 69 participants.
The verdict
NCT01396551, a NA study, has completed, sponsored by Varian, a Siemens Healthineers Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
Clinical study investigating the feasibility and safety of using an anchored Calypso transponder in the airways of the lung for real-time monitoring of tumor location during radiotherapy
Interventions
- DEVICE Implantation of anchored Beacon transponder in the lung
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-10 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01396551
The ClinicalTrials.gov registry entry for NCT01396551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Varian, a Siemens Healthineers Company, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantation of anchored Beacon transponder in the lung is the first listed.
NCT01396551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01396551 about?
NCT01396551 is a clinical study titled "Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy". Clinical study investigating the feasibility and safety of using an anchored Calypso transponder in the airways of the lung for real-time monitoring of tumor location during radiotherapy
What is the current status of trial NCT01396551?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2010-10. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01396551?
The interventions under investigation include: Implantation of anchored Beacon transponder in the lung (DEVICE).
Who is sponsoring clinical trial NCT01396551?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.